| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |